F2 and COVID-19: Among all proteins that were detected in this pathway, the decreased abundance of the substrate and the increased abundance of the end products suggested an activation of the complement and coagulation cascade, which is consistent with published studies and clinical data of COVID-19 patients with coagulation problems, such a prolonged prothrombin time (PT) and increased fibrin degradation products [9, 43, 66, 67].